Equity
€90,265 from €3.4m in 2017
Equity fell by 97% in 8 years.
Oncurious
Lifetime
11 annual accounts with figures on one time axispeak €944,413 (2020)
-€5,951▲ €14,770
lowest -€4.5m (2020)
-€6,278▲ €21,699
peak €3.4m (2017)
€90,265▼ 6.5%
€70,197▼ 52.2%
peak 5.6 FTE (2021)
-not published
Board12 names since 2015
2 directors and 1 other
Owners2 names in the annual accounts
consolidates
Documentsfilings and deeds
30-09-202661 days late
2025abbreviated format
Gross margin from -€20,722 to -€5,951Loss of €6,278Debts from €146,726 to €70,197Cash from €82,776 to €3
Key points
from the 2025 annual accountsLosses
-€12.6m in eleven years
Every financial year from 2015 to 2025 closed with a loss. 2020 was the heaviest.
Liquidity
5.95 was 11.29 in 2024
Short-term debts rose from €21,553 to €26,965.
Filings
11 annual accounts 61 days
Latest accounts filed late: after the legal deadline.
Board
1 joined · 1 left
Board changed. Latest change 02-03-2026 · 2 in office.
Position in the sector
-€6,278
Lower net result than 90% of companies in human health. Sector median €125,403 · 2,767 companies.
Turnover not published (abbreviated format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,920 companies had the same profile as Oncurious has now. Each dot stands for 18 companies, two years later.
90.7%
were still trading
8.0%
stopped another way
1.1%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,920 companies, not a prediction for Oncurious. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, , since 21-03-2024
Director
Auditor,
- 100%score equity -€12.2m (2025) · 2025 annual accounts of
- consolidatesannual accounts 2025
Recent changes
Registered office moved to Brussels
New registered office: Brussels Gewest, 1000 Brussel, Werkhuizenkaai 160 · Previous registered office: Vlaamse Gewest · Resignation: (director) · General meeting of 18-08-2026 · Gazette deed
Address struck
effective 15-03-2026 · KBO administration
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0627952462
2 directors appointed, 2 resignations
Resignations: and · Permanent representative: · Appointments: and · General meeting of 21-03-2024 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Oncurious Brussels | €160,462 | -€5,951 | 56.3% | - |
| THALIA Grez-Doiceau | €132,673 | -€12,686 | 63.4% | - |
| DELANCEY Waterloo | €109,948 | -€901 | 99.8% | - |
| CHROMETRA Kortenaken | €97,221 | -€21,760 | 28.7% | - |
| DANOS LABORATORY Ixelles | €297,522 | -€27,299 | 38.0% | - |
| ABBIO Watermael-Boitsfort | €388,415 | -€97,079 | -22.6% | - |
| CRYOSTORAGE Ghent | €398,857 | -€453 | -30.2% | - |
These companies have the same main activity as Oncurious: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €97,200 and €399,000, founded between 2008 and 2015.
Official details
Source: KBO- Status
- Active since 03-04-2015Normal situation
- Registered office
- 43 active companies are registered at this address13 started in the 12 months before. Source: KBO register, as of 14 November 2026.
- Activity
- Medical imaging and medical laboratoriesNACE 86910
- Joint committee
- 207White-collar workers in the chemical industry · annual accounts 2021
- Establishment unit
- 2.265.755.7911000 Brussels, since 01-06-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 17-12-2025
Insights on Oncurious
Oncurious files the abbreviated format. That format states no turnover. The gross margin fell from €30,047 in 2016 to -€5,951 in 2025.
holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Oncurious
- What is the company number of Oncurious?
- The company number of Oncurious is 0627.952.462. The VAT number is the same number with BE in front: BE 0627.952.462.
- Where is Oncurious based?
- The registered office is at Werkhuizenkaai 160, 1000 Brussels.Company details
- What does Oncurious do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of Oncurious?
- Oncurious is a public limited company (NV).
- When was Oncurious founded?
- Oncurious was founded on 03-04-2015.
- Is Oncurious still active?
- Yes, Oncurious is an active enterprise in the KBO register.
- How many employees does Oncurious have?
- Oncurious had an average of 5.6 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
- Which joint committee does Oncurious fall under?
- In its 2021 annual accounts, Oncurious states joint committee 207 (White-collar workers in the chemical industry).
- What is the turnover of Oncurious?
- The annual accounts for financial year 2025 state no turnover. The abbreviated format does not require it.
- Is Oncurious profitable?
- In financial year 2025, Oncurious made a loss of €6,278.
- Where can I find the annual accounts of Oncurious?
- Oncurious filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Oncurious due?
- Oncurious must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.